312 related articles for article (PubMed ID: 16960915)
1. Adenoviral vector platform for transduction of constitutive and regulated tricistronic or triple-transcript transgene expression in mammalian cells and microtissues.
Gonzalez-Nicolini V; Sanchez-Bustamante CD; Hartenbach S; Fussenegger M
J Gene Med; 2006 Oct; 8(10):1208-22. PubMed ID: 16960915
[TBL] [Abstract][Full Text] [Related]
2. Design and in vivo characterization of self-inactivating human and non-human lentiviral expression vectors engineered for streptogramin-adjustable transgene expression.
Mitta B; Weber CC; Rimann M; Fussenegger M
Nucleic Acids Res; 2004 Jul; 32(12):e106. PubMed ID: 15258250
[TBL] [Abstract][Full Text] [Related]
3. A novel synthetic mammalian promoter derived from an internal ribosome entry site.
Hartenbach S; Fussenegger M
Biotechnol Bioeng; 2006 Nov; 95(4):547-59. PubMed ID: 16924671
[TBL] [Abstract][Full Text] [Related]
4. A novel binary adenovirus-based dual-regulated expression system for independent transcription control of two different transgenes.
Gonzalez-Nicolini V; Fussenegger M
J Gene Med; 2005 Dec; 7(12):1573-85. PubMed ID: 16052603
[TBL] [Abstract][Full Text] [Related]
5. Autoregulated, bidirectional and multicistronic gas-inducible mammalian as well as lentiviral expression vectors.
Hartenbach S; Fussenegger M
J Biotechnol; 2005 Oct; 120(1):83-98. PubMed ID: 16026881
[TBL] [Abstract][Full Text] [Related]
6. A novel vector platform for vitamin H-inducible transgene expression in mammalian cells.
Weber W; Bacchus W; Gruber F; Hamberger M; Fussenegger M
J Biotechnol; 2007 Aug; 131(2):150-8. PubMed ID: 17669538
[TBL] [Abstract][Full Text] [Related]
7. Toward higher order control modalities in mammalian cells-independent adjustment of two different gene activities.
Fux C; Fussenegger M
Biotechnol Prog; 2003; 19(1):109-20. PubMed ID: 12573013
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus-mediated transduction of auto- and dual-regulated transgene expression in mammalian cells.
Gonzalez-Nicolini V; Fussenegger M
Methods Mol Biol; 2008; 434():221-37. PubMed ID: 18470648
[TBL] [Abstract][Full Text] [Related]
9. Artificial regulatory networks and cascades for discrete multilevel transgene control in mammalian cells.
Kramer BP; Weber W; Fussenegger M
Biotechnol Bioeng; 2003 Sep; 83(7):810-20. PubMed ID: 12889021
[TBL] [Abstract][Full Text] [Related]
10. Macrolide-based transgene control in mammalian cells and mice.
Weber W; Fux C; Daoud-el Baba M; Keller B; Weber CC; Kramer BP; Heinzen C; Aubel D; Bailey JE; Fussenegger M
Nat Biotechnol; 2002 Sep; 20(9):901-7. PubMed ID: 12205509
[TBL] [Abstract][Full Text] [Related]
11. A novel mammalian expression system derived from components coordinating nicotine degradation in arthrobacter nicotinovorans pAO1.
Malphettes L; Weber CC; El-Baba MD; Schoenmakers RG; Aubel D; Weber W; Fussenegger M
Nucleic Acids Res; 2005 Jul; 33(12):e107. PubMed ID: 16002786
[TBL] [Abstract][Full Text] [Related]
12. Novel macrolide-adjustable bidirectional expression modules for coordinated expression of two different transgenes in mice.
Fux C; Weber W; Daoud-El Baba M; Heinzen C; Aubel D; Fussenegger M
J Gene Med; 2003 Dec; 5(12):1067-79. PubMed ID: 14661182
[TBL] [Abstract][Full Text] [Related]
13. Bidirectional expression units enable streptogramin-adjustable gene expression in mammalian cells.
Fux C; Fussenegger M
Biotechnol Bioeng; 2003 Sep; 83(5):618-25. PubMed ID: 12827704
[TBL] [Abstract][Full Text] [Related]
14. Dual-regulated expression technology: a new era in the adjustment of heterologous gene expression in mammalian cells.
Moser S; Rimann M; Fux C; Schlatter S; Bailey JE; Fussenegger M
J Gene Med; 2001; 3(6):529-49. PubMed ID: 11778900
[TBL] [Abstract][Full Text] [Related]
15. New-generation multicistronic expression platform: pTRIDENT vectors containing size-optimized IRES elements enable homing endonuclease-based cistron swapping into lentiviral expression vectors.
Fux C; Langer D; Kelm JM; Weber W; Fussenegger M
Biotechnol Bioeng; 2004 Apr; 86(2):174-87. PubMed ID: 15052637
[TBL] [Abstract][Full Text] [Related]
16. Versatile macrolide-responsive mammalian expression vectors for multiregulated multigene metabolic engineering.
Weber W; Marty RR; Keller B; Rimann M; Kramer BP; Fussenegger M
Biotechnol Bioeng; 2002 Dec; 80(6):691-705. PubMed ID: 12378611
[TBL] [Abstract][Full Text] [Related]
17. SV40-derived vectors provide effective transgene expression and inhibition of HIV-1 using constitutive, conditional,and pol III promoters.
Jayan GC; Cordelier P; Patel C; BouHamdan M; Johnson RP; Lisziewicz J; Pomerantz RJ; Strayer DS
Gene Ther; 2001 Jul; 8(13):1033-42. PubMed ID: 11438838
[TBL] [Abstract][Full Text] [Related]
18. Heterologous protein production capacity of mammalian cells cultivated as monolayers and microtissues.
Sanchez-Bustamante CD; Kelm JM; Mitta B; Fussenegger M
Biotechnol Bioeng; 2006 Jan; 93(1):169-80. PubMed ID: 16255048
[TBL] [Abstract][Full Text] [Related]
19. High-level recombinant protein production in CHO cells using an adenoviral vector and the cumate gene-switch.
Gaillet B; Gilbert R; Amziani R; Guilbault C; Gadoury C; Caron AW; Mullick A; Garnier A; Massie B
Biotechnol Prog; 2007; 23(1):200-9. PubMed ID: 17269689
[TBL] [Abstract][Full Text] [Related]
20. High-level expression of proteins in mammalian cells using transcription regulatory sequences from the Chinese hamster EF-1alpha gene.
Running Deer J; Allison DS
Biotechnol Prog; 2004; 20(3):880-9. PubMed ID: 15176895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
